| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dugel Pravin |
President |
• • – |
2023-05-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,312 |
203,035 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-05-02 |
4 |
AS |
$37.81 |
$756,200 |
D/D |
(20,000) |
39,652 |
|
6% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-05-02 |
4 |
OE |
$2.94 |
$58,800 |
D/D |
20,000 |
59,652 |
|
- |
|
| Carroll David Francis |
SVP, Chief Financial Officer |
• – – |
2023-05-01 |
4 |
AS |
$37.04 |
$2,352,040 |
D/D |
(63,500) |
68,472 |
|
5% |
|
| Carroll David Francis |
SVP, Chief Financial Officer |
• – – |
2023-05-01 |
4 |
OE |
$2.81 |
$178,435 |
D/D |
63,500 |
131,972 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-05-01 |
4 |
AS |
$37.12 |
$742,400 |
D/D |
(20,000) |
39,652 |
|
5% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-05-01 |
4 |
OE |
$4.52 |
$98,250 |
D/D |
20,000 |
50,866 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-04-24 |
4 |
AS |
$30.07 |
$564,775 |
D/D |
(18,782) |
39,652 |
|
26% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-04-24 |
4 |
OE |
$4.52 |
$84,895 |
D/D |
18,782 |
58,434 |
|
- |
|
| Carroll David Francis |
SVP, Chief Financial Officer |
• – – |
2023-04-24 |
4 |
AS |
$30.21 |
$1,455,246 |
D/D |
(48,171) |
68,472 |
|
26% |
|
| Carroll David Francis |
SVP, Chief Financial Officer |
• – – |
2023-04-24 |
4 |
OE |
$1.45 |
$69,848 |
D/D |
48,171 |
116,643 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-04-21 |
4 |
AS |
$30.00 |
$36,540 |
D/D |
(1,218) |
39,652 |
|
34% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-04-21 |
4 |
OE |
$4.52 |
$5,505 |
D/D |
1,218 |
40,870 |
|
- |
|
| Carroll David Francis |
SVP, Chief Financial Officer |
• – – |
2023-04-21 |
4 |
AS |
$30.00 |
$54,870 |
D/D |
(1,829) |
68,472 |
|
34% |
|
| Carroll David Francis |
SVP, Chief Financial Officer |
• – – |
2023-04-21 |
4 |
OE |
$1.45 |
$2,652 |
D/D |
1,829 |
70,301 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-04-03 |
4 |
AS |
$26.35 |
$1,068,194 |
D/D |
(40,000) |
39,652 |
|
51% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-04-03 |
4 |
OE |
$1.45 |
$128,659 |
D/D |
40,000 |
79,652 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-03-02 |
4 |
AS |
$23.91 |
$478,614 |
D/D |
(20,000) |
39,652 |
|
69% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-03-02 |
4 |
OE |
$1.45 |
$19,282 |
D/D |
13,298 |
59,652 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-02-17 |
4 |
AS |
$25.05 |
$375,750 |
D/D |
(15,000) |
46,354 |
|
78% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-02-17 |
4 |
OE |
$2.94 |
$61,818 |
D/D |
15,000 |
57,568 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-02-02 |
4 |
AS |
$23.82 |
$476,400 |
D/D |
(20,000) |
46,354 |
|
59% |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-02-01 |
4 |
AS |
$23.03 |
$460,600 |
D/D |
(20,000) |
66,354 |
|
61% |
|
| Miller Christine Ann |
Director |
– • – |
2023-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Westby Keith |
SVP, Chief Operating Officer |
• – – |
2023-01-03 |
4 |
S |
$20.06 |
$69,809 |
D/D |
(3,480) |
86,354 |
|
-87% |
|
468 Records found
|
|
Page 2 of 19 |
|
|
